Page last updated: 2024-08-25

doripenem and Pneumococcal Infections

doripenem has been researched along with Pneumococcal Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Lin, CN; Lin, CY; Liu, CP; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tang, HJ; Tsai, YT; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY1
Ishibashi, T; Katsube, T; Matsumoto, S; Matsuo, Y; Wajima, T1
Ishii, Y; Miyazaki, S; Ohno, A; Tsuji, M; Yamaguchi, K1

Other Studies

3 other study(ies) available for doripenem and Pneumococcal Infections

ArticleYear
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2022, Volume: 55, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Levofloxacin; Linezolid; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Taiwan; Vancomycin

2022
Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen Assessment.
    Journal of pharmaceutical sciences, 2019, Volume: 108, Issue:9

    Topics: Adolescent; Anti-Bacterial Agents; Biological Variation, Population; Body Weight; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Computer Simulation; Doripenem; Drug Administration Schedule; Drug Dosage Calculations; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Multicenter Studies as Topic; Pneumococcal Infections; Sex Factors; Streptococcus pneumoniae

2019
In vitro and in vivo antibacterial activities of S-4661, a new carbapenem.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Doripenem; Enterobacteriaceae; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Moraxella; Penicillin Resistance; Pneumococcal Infections

1998